MABSC

July 20, 2018July 20, 2018

AIT’s Inhaled Nitric Oxide Shows Potential in Fighting Bacterial Infection Prevalent in CF Patients

cystic fibrosis, News

Inhaled nitric oxide (NO) was shown to be an effective antibacterial agent against Mycobacterium abscessus infection in preclinical studies, as well as in a pilot clinical trial, according to AIT Therapeutics. ... Read more

June 29, 2018June 29, 2018

AIT Therapeutics to Present New Data on Nitric Oxide’s Ability to Clear Mycobacterium Lung Infections

cystic fibrosis, News

AIT Therapeutics will present new research on the use of inhaled nitric oxide in the treatment of Mycobacterium abscessus lung infections at an upcoming conference, the company recently announced. Data ... Read more

May 25, 2018May 25, 2018

#ATS2018 – Nitric Oxide-Inhaled Therapy May Decrease Burden of Serious Lungs Infections, Study Shows

cystic fibrosis, News

New data suggest that inhalation of nitric oxide (NO) may improve lung function and alleviate the burden of serious lung infections, such as Mycobacterium abscessus complex (MABSC) and Pseudomonas aeruginosa, two ... Read more

January 24, 2018January 24, 2018

AIT’s Nitric Oxide Mist Lowers CF Patients’ Airway Bacteria by 65%, Phase 2 Trial Shows

cystic fibrosis, News

AIT Therapeutics’ nitric oxide mist led to a 65 percent reduction in cystic fibrosis patients’ airway bacteria and an improvement in their exercise capability 60 days after treatment, a ... Read more

December 1, 2017December 1, 2017

AIT’s Nitric Oxide Therapy Helps CF Patients with an Infection Breathe and Function Better

cystic fibrosis, News

AIT Therapeutics’ inhaled nitric oxide formulation improved the breathing and physical functioning of cystic fibrosis patients with a lung infection, a Phase 2 clinical trial shows. The preliminary results ... Read more

September 18, 2017September 18, 2017

AIT Therapeutics’ Nitric Oxide Therapy Counters Two Patients’ Drug-resistant Bacteria

cystic fibrosis, News

A nitric oxide therapy that AIT Therapeutics‘ is developing to treat respiratory diseases eradicated a drug-resistant bacteria in one cystic fibrosis patient and reduced it in another, according to a ... Read more

August 9, 2017August 9, 2017

AIT Administers First Doses of Nitric Oxide in a Trial Testing Its Ability to Kill Drug-resistant Bacteria

News

AIT Therapeutics has administered its first doses of nitric oxide in a Phase 2 clinical trial of the compound’s ability to kill the drug-resistant bacteria often found in cystic fibrosis ... Read more

May 2, 2017May 2, 2017

Tube Feeding Could Be Source of Drug-resistant Bacteria in CF Patients, Study Reports

cystic fibrosis, News

Multi-drug-resistant nontuberculous mycobacteria (NTM) can be found in the gastric juice and tubes that are used to feed some cystic fibrosis (CF) patients, research shows. Tube feeding, known as ... Read more

Pin It on Pinterest